{"nct_id":"NCT02509507","title":"Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611","status":"COMPLETED","status_verified_date":"2024-07","start_date":"2016-02-05","start_date_type":"ACTUAL","primary_completion_date":"2022-02-14","primary_completion_date_type":"ACTUAL","completion_date":"2023-07-11","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["AMGN"]}